Clinical biomarker‐based biological aging and risk of benign prostatic hyperplasia: A large prospective cohort study

Autor: Qiao Huang, Bing‐Hui Li, Yong‐Bo Wang, Hao Zi, Yuan‐Yuan Zhang, Fei Li, Cheng Fang, Shi‐Di Tang, Ying‐Hui Jin, Jiao Huang, Xian‐Tao Zeng
Jazyk: angličtina
Rok vydání: 2024
Předmět:
Zdroj: Aging Medicine, Vol 7, Iss 3, Pp 393-405 (2024)
Druh dokumentu: article
ISSN: 2475-0360
DOI: 10.1002/agm2.12331
Popis: Abstract Objective Chronological age (CAge), biological age (BAge), and accelerated age (AAge) are all important for aging‐related diseases. CAge is a known risk factor for benign prostatic hyperplasia (BPH); However, the evidence of association of BAge and AAge with BPH is limited. This study aimed to evaluate the association of CAge, Bage, and AAge with BPH in a large prospective cohort. Method A total of 135,933 males without BPH at enrolment were extracted from the UK biobank. We calculated three BAge measures (Klemera–Doubal method, KDM; PhenoAge; homeostatic dysregulation, HD) based on 16 biomarkers. Additionally, we calculated KDM‐BAge and PhenoAge‐BAge measures based on the Levine method. The KDM‐AAge and PhenoAge‐AAge were assessed by the difference between CAge and BAge and were standardized (mean = 0 and standard deviation [SD] = 1). Cox proportional hazard models were applied to assess the associations of CAge, Bage, and AAge with incident BPH risk. Results During a median follow‐up of 13.150 years, 11,811 (8.690%) incident BPH were identified. Advanced CAge and BAge measures were associated with an increased risk of BPH, showing threshold effects at a later age (all P for nonlinearity 2 SD) had a significantly elevated BPH risk with hazard ratio (HR) of 1.115 (95% CI, 1.000–1.223) for KDM‐AAge and 1.180 (95% CI, 1.068–1.303) for PhenoAge‐AAge, respectively. For PhenoAge‐AAge, subgroup analysis of the accelerated aging group showed an increased HR of 1.904 (95% CI, 1.374–2.639) in males with CAge
Databáze: Directory of Open Access Journals